人工臓器・バイオニクスの世界市場レポート 2025年

人工臓器・バイオニクスの市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR11.9％で567億1,000万米ドルに成長します。予測期間の成長は、ヘルスケア支出の増加、個別化医療、規制当局の支援と承認の合理化、3Dプリンティングの急速な進歩、共同研究やパートナーシップに起因しています。予測期間の主な動向には、小型化とウェアラブル技術、技術の進歩、先進材料の統合、設計におけるAIと機械学習、3Dプリンティングとバイオプリンティングの進歩が含まれます。

ヘルスケア支出の増加は、今後の人工臓器・バイオニクス市場の成長を促進すると予測されます。ヘルスケア支出には、民間および公的健康保険、ヘルスリサーチ、公衆衛生イニシアチブを含むヘルスケアおよび関連活動への総支出が含まれます。ヘルスケアへの投資は技術革新を促進し、より高度で効率的な人工臓器の開発につながります。これには、材料、設計、製造プロセスの向上が含まれます。例えば、2023年12月、米国連邦政府機関であるメディケアメディケイドサービスセンターは、米国の国民医療費が2021年の2.7％増から2022年には4.3％増になったと報告しました。このように、ヘルスケア支出の増加が人工臓器・バイオニクス市場を前進させています。

移植件数の増加が今後の人工臓器・バイオニクス市場の成長を牽引すると予測されています。移植とは、組織や臓器をドナーからレシピエントへ、あるいは身体のある部位から別の部位へ移植する外科的処置を指します。人工臓器は、損傷した臓器の代わりとなり、その特定の機能を再現するために体内に埋め込まれる装置であり、患者が通常の生活を送ることを可能にします。例えば、2024年1月、米国を拠点とする組織である臓器調達・移植ネットワーク（OPTN）は、2023年に生死両方のドナーを用いて行われた臓器移植は合計4万6,632件であったと報告しました。これは2022年と比較して8.7％増、初めて4万件を超えた2021年からは12.7％増となりました。このうち、死亡ドナーからの移植は3万9,679件で、前年比8.9％増となり、11年連続で記録を更新しました。このように、移植件数の増加が人工臓器・バイオニクス市場を大きく押し上げることが予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の人工臓器・バイオニクス市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の人工臓器・バイオニクス市場：成長率分析
• 世界の人工臓器・バイオニクス市場の実績：規模と成長、2019～2024年
• 世界の人工臓器・バイオニクス市場の予測：規模と成長、2024～2029年、2034年
• 世界の人工臓器・バイオニクス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の人工臓器・バイオニクス市場：製品別、実績と予測、2019～2024年、2024～2029年、2034年
• 人工臓器
• 人工バイオニクス
• 世界の人工臓器・バイオニクス市場：固定タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 埋め込み型・外部装着型
• 心臓バイオニクス・脳バイオニクス
• 世界の人工臓器・バイオニクス市場：技術別、実績と予測、2019～2024年、2024～2029年、2034年
• メカニカルバイオニクス
• 電子バイオニクス
• 人工臓器・バイオニクス
• 世界の人工臓器・バイオニクス市場：人工臓器のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 人工心臓
• 人工腎臓
• 人工肝臓
• 人工膵臓
• 人工肺
• 世界の人工臓器・バイオニクス市場：人工バイオニクスのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• バイオニックリム
• バイオニックアイ
• 外骨格
• 神経補綴

第7章 地域別・国別分析

• 世界の人工臓器・バイオニクス市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の人工臓器・バイオニクス市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 人工臓器・バイオニクス市場：競合情勢
• 人工臓器・バイオニクス市場：企業プロファイル
  • Abiomed Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Asahi Kasei Medical Co., Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Baxter Overview, Products and Services, Strategy and Financial Analysis
  • Berlin Heart GmbH Overview, Products and Services, Strategy and Financial Analysis
  • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Cyberonics Inc.
• Ekso Bionics Holdings Inc.
• Getinge AB
• Medtronic PLC
• Bornlife Prosthetic and Orthotic Inc.
• Sonova
• LifeNet Health
• Terumo Corporation
• Nano Retina Ltd
• Edwards Lifesciences Corporation
• Orthofix Medical Inc
• Cochlear Limited
• Advanced Bionics AG
• Ottobock SE & Co. KGaA
• Second Sight Medical Products Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 人工臓器・バイオニクス市場2029年：新たな機会を提供する国
• 人工臓器・バイオニクス市場2029年：新たな機会を提供するセグメント
• 人工臓器・バイオニクス市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Artificial organs and bionics encompass machines or devices designed to substitute the functions of a deficient or absent human organ, while bionics involves constructing artificial systems mirroring certain characteristics of living organisms. Their primary objective is to enhance an individual's lifespan and functionality.

Within this domain, the main products include artificial organs and artificial bionics. Artificial organs are devices utilized to replicate the functions of missing or impaired human organs or body parts. These can be categorized based on fixation types as either implantable or externally-worn, and further segmented into cardiac bionics and brain bionics. The technologies encompassed within this field encompass mechanical bionics and electronic bionics.

The artificial organ and bionics market research report is one of a series of new reports from The Business Research Company that provides artificial organ and bionics market statistics, including artificial organ and bionics industry global market size, regional shares, competitors with an artificial organ and bionics market share, detailed artificial organ and bionics market segments, market trends and opportunities, and any further data you may need to thrive in the artificial organ and bionics industry. This artificial organ and bionics market research report deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial organ and bionics market size has grown rapidly in recent years. It will grow from$32.82 billion in 2024 to $36.14 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to rising chronic diseases, medical innovation and research, growing acceptance of transplants, government initiatives and funding, improvements in biocompatibility

The artificial organ and bionics market size is expected to see rapid growth in the next few years. It will grow to $56.71 billion in 2029 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to increasing healthcare expenditure, personalized medicine, regulatory support and streamlined approvals, rapid advancements in 3d printing, collaborations and partnerships. Major trends in the forecast period include miniaturization and wearable technology, technological advancements, advanced materials integration, ai and machine learning in design, 3d printing and bioprinting advancements.

Increasing healthcare expenditure is anticipated to drive the growth of the artificial organ and bionics market in the future. Healthcare expenditure encompasses the total spending on health care and related activities, including both private and public health insurance, health research, and public health initiatives. Investments in healthcare facilitate technological innovations, leading to the development of more advanced and efficient artificial organs. This may involve enhancements in materials, design, and manufacturing processes. For example, in December 2023, the Centers for Medicare and Medicaid Services, a U.S. federal agency, reported that national health expenditures in the United States grew by 4.3% in 2022, up from a 2.7% increase in 2021. Consequently, rising healthcare expenditure is propelling the artificial organ and bionics market forward.

An increasing number of transplants is projected to drive the growth of the artificial organ and bionics market in the future. A transplant involves the surgical procedure where a tissue or organ is transferred from a donor to a recipient, or from one part of the body to another. Artificial organs are devices implanted in the body to replace damaged organs and replicate their specific functions, enabling patients to lead a normal life. For example, in January 2024, the Organ Procurement and Transplantation Network (OPTN), a U.S.-based organization, reported that in 2023, there were a total of 46,632 organ transplants performed using both living and deceased donors. This marked an 8.7% increase compared to 2022 and a 12.7% rise from 2021, the first year to surpass 40,000 transplants. Among these, 39,679 transplants were from deceased donors, reflecting an 8.9% increase from the previous year and setting a record for the eleventh consecutive year. Thus, the growing number of transplants is expected to significantly boost the artificial organ and bionics market.

Major corporate investments are steering the transformation of organ transplantation within the artificial organs and bionics market. These investments play a pivotal role in fostering the development of artificial organs, addressing the scarcity of donor organs by creating functional and biocompatible replacements. This not only offers hope to patients awaiting organ transplants but also holds the potential to revolutionize the landscape of transplantation medicine. An exemplar is the Government of Canada's investment of $2 million in April 2022 towards innovative organ and tissue donation projects, aimed at enhancing organ donation and transplantation efficacy in Canada. This funding aligns with the Networks of Centres of Excellence Program, dedicated to supporting organ donation and transplantation research.

Leading companies in the artificial organ and bionics market are advancing technologies like hearing devices to enhance connectivity, improve user experiences, and enable seamless integration between various devices. Hearing technology includes devices and solutions aimed at assisting individuals with hearing impairments, such as hearing aids and cochlear implants. For example, in November 2022, Cochlear Limited, an Australia-based medical device company, received approval from the U.S. Food and Drug Administration (FDA) for the Nucleus 8 Sound Processor. This device is designed to offer improved sound quality, enhanced connectivity, and user-friendly features, including compatibility with Bluetooth LE Audio technology. This innovation allows users to connect wirelessly to multiple devices, such as smartphones and televisions, creating a more integrated and streamlined listening experience.

In December 2022, Johnson & Johnson, a prominent healthcare products company based in the US, successfully acquired Abiomed Inc. for an undisclosed sum. This strategic acquisition is poised to expedite Johnson & Johnson's progress in providing cutting-edge medical technologies and advancing its MedTech business on a global scale. Abiomed Inc., also based in the US, operates within the sphere of artificial organs and bionics, making its acquisition a significant move for Johnson & Johnson as it aims to further its presence and innovation within this specialized domain.

Major companies operating in the artificial organ and bionics market include Abiomed Inc., Asahi Kasei Medical Co., Ltd, Baxter, Berlin Heart GmbH, Boston Scientific Corporation, Cyberonics Inc., Ekso Bionics Holdings Inc., Getinge AB, Medtronic PLC, Bornlife Prosthetic and Orthotic Inc., Sonova, LifeNet Health, Terumo Corporation, Nano Retina Ltd, Edwards Lifesciences Corporation, Orthofix Medical Inc, Cochlear Limited, Advanced Bionics AG, Ottobock SE & Co. KGaA, Second Sight Medical Products Inc., iWalk Inc., Jarvik Heart Inc, St. Jude Medical Inc., Harmonic Bionics Inc., Open Bionics, Beta Bionics Inc., Bionic Prosthetics and Orthotics, Mobius Bionics, Touch Bionics Ltd, Phytowelt GreenTechnologies GmbH

North America was the largest region in the artificial organ and bionics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global artificial organ and bionics market report during the forecast period. The regions covered in the artificial organ and bionics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the artificial organ and bionics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The artificial organs and bionics market consists of sales of artificial hearts, total artificial hearts (TAH), artificial kidneys, artificial livers, ear bionics, vision bionics, orthopaedic bionics, and heart bionics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Organ And Bionics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial organ and bionics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial organ and bionics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial organ and bionics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Artificial Organs; Artificial Bionics
• 2) By Fixation Type: Implantable And Externally-Worn; Cardiac Bionics And Brain Bionics
• 3) By Technology: Mechanical Bionics; Electronic Bionics
• Subsegments:
• 1) By Artificial Organs: Artificial Heart; Artificial Kidney; Artificial Liver; Artificial Pancreas; Artificial Lungs
• 2) By Artificial Bionics: Bionic Limbs; Bionic Eyes; Exoskeletons; Neural Prosthetics
• Companies Mentioned: Abiomed Inc.; Asahi Kasei Medical Co., Ltd; Baxter; Berlin Heart GmbH; Boston Scientific Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Organ And Bionics Market Characteristics

3. Artificial Organ And Bionics Market Trends And Strategies

4. Artificial Organ And Bionics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Artificial Organ And Bionics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Artificial Organ And Bionics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Artificial Organ And Bionics Market Growth Rate Analysis
• 5.4. Global Artificial Organ And Bionics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Artificial Organ And Bionics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Artificial Organ And Bionics Total Addressable Market (TAM)

6. Artificial Organ And Bionics Market Segmentation

• 6.1. Global Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Artificial Organs
• Artificial Bionics
• 6.2. Global Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Implantable And Externally-Worn
• Cardiac Bionics And Brain Bionics
• 6.3. Global Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mechanical Bionics
• Electronic Bionics
• Artificial Organ And Bionics
• 6.4. Global Artificial Organ And Bionics Market, Sub-Segmentation Of Artificial Organs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Artificial Heart
• Artificial Kidney
• Artificial Liver
• Artificial Pancreas
• Artificial Lungs
• 6.5. Global Artificial Organ And Bionics Market, Sub-Segmentation Of Artificial Bionics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bionic Limbs
• Bionic Eyes
• Exoskeletons
• Neural Prosthetics

7. Artificial Organ And Bionics Market Regional And Country Analysis

• 7.1. Global Artificial Organ And Bionics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Artificial Organ And Bionics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Organ And Bionics Market

• 8.1. Asia-Pacific Artificial Organ And Bionics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Organ And Bionics Market

• 9.1. China Artificial Organ And Bionics Market Overview
• 9.2. China Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Organ And Bionics Market

• 10.1. India Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Organ And Bionics Market

• 11.1. Japan Artificial Organ And Bionics Market Overview
• 11.2. Japan Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Organ And Bionics Market

• 12.1. Australia Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Organ And Bionics Market

• 13.1. Indonesia Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Organ And Bionics Market

• 14.1. South Korea Artificial Organ And Bionics Market Overview
• 14.2. South Korea Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Organ And Bionics Market

• 15.1. Western Europe Artificial Organ And Bionics Market Overview
• 15.2. Western Europe Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Organ And Bionics Market

• 16.1. UK Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Organ And Bionics Market

• 17.1. Germany Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Organ And Bionics Market

• 18.1. France Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Organ And Bionics Market

• 19.1. Italy Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Organ And Bionics Market

• 20.1. Spain Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Organ And Bionics Market

• 21.1. Eastern Europe Artificial Organ And Bionics Market Overview
• 21.2. Eastern Europe Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Organ And Bionics Market

• 22.1. Russia Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Organ And Bionics Market

• 23.1. North America Artificial Organ And Bionics Market Overview
• 23.2. North America Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Organ And Bionics Market

• 24.1. USA Artificial Organ And Bionics Market Overview
• 24.2. USA Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Organ And Bionics Market

• 25.1. Canada Artificial Organ And Bionics Market Overview
• 25.2. Canada Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Organ And Bionics Market

• 26.1. South America Artificial Organ And Bionics Market Overview
• 26.2. South America Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Organ And Bionics Market

• 27.1. Brazil Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Organ And Bionics Market

• 28.1. Middle East Artificial Organ And Bionics Market Overview
• 28.2. Middle East Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Organ And Bionics Market

• 29.1. Africa Artificial Organ And Bionics Market Overview
• 29.2. Africa Artificial Organ And Bionics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Artificial Organ And Bionics Market, Segmentation By Fixation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Artificial Organ And Bionics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Organ And Bionics Market Competitive Landscape And Company Profiles

• 30.1. Artificial Organ And Bionics Market Competitive Landscape
• 30.2. Artificial Organ And Bionics Market Company Profiles
  • 30.2.1. Abiomed Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Asahi Kasei Medical Co., Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Baxter Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Berlin Heart GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Organ And Bionics Market Other Major And Innovative Companies

• 31.1. Cyberonics Inc.
• 31.2. Ekso Bionics Holdings Inc.
• 31.3. Getinge AB
• 31.4. Medtronic PLC
• 31.5. Bornlife Prosthetic and Orthotic Inc.
• 31.6. Sonova
• 31.7. LifeNet Health
• 31.8. Terumo Corporation
• 31.9. Nano Retina Ltd
• 31.10. Edwards Lifesciences Corporation
• 31.11. Orthofix Medical Inc
• 31.12. Cochlear Limited
• 31.13. Advanced Bionics AG
• 31.14. Ottobock SE & Co. KGaA
• 31.15. Second Sight Medical Products Inc.

32. Global Artificial Organ And Bionics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Organ And Bionics Market

34. Recent Developments In The Artificial Organ And Bionics Market

35. Artificial Organ And Bionics Market High Potential Countries, Segments and Strategies

• 35.1 Artificial Organ And Bionics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Artificial Organ And Bionics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Artificial Organ And Bionics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer